ABSTRACT Cancer is one of the deadliest diseases in the world and is responsible for around 13% of all deaths worldwide. Cancer incidence rate is growing at an alarming rate in the world. Despite the fact that cancer is preventable and curable in early stages, the vast majority of patients are diagnosed with cancer very late. Furthermore, cancer commonly comes back after years of treatment. Therefore, it is of paramount importance to predict cancer recurrence so that specific treatments can be sought. Nonetheless, conventional methods of predicting cancer recurrence rely solely on histopathology and the results are not very reliable. The microarray gene expression technology is a promising technology that could predict cancer recurrence by...
Motivation: Patient outcome prediction using microarray technolo-gies is an important application in...
Objective Colorectal cancer (CRC) is the most common cancer worldwide. Patient outcomes following re...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Cancer is one of the deadliest diseases in the world and is responsible for around 13% of all deaths...
Cancer is one of the deadliest diseases in the world and is responsible for around 13% of all deaths...
Cancer is a major deadliest disease globally that involve uncontrolled cell growth and invasion-meta...
After numerous breakthroughs in medicine, microbiology, and pathology in the past century, lung canc...
Background: The prognosis of cancer recurrence is an important research area in bioinformatics and i...
In the last decades, several gene expression-based predictors of clinical behavior were developed fo...
Background. After curative surgical resection, about 30-75% lung adenocarcinoma (LUAD) patients suff...
[[abstract]]Background: Microarray technology can acquire information about thousands of genes simul...
AbstractAn accurate prognostic model of a cancer patient after treatment can be useful in deciding t...
MOTIVATION: In recent years, microarray technology has revealed many tumor-expressed genes prognosti...
Microarrays are being increasingly used in cancer research for a better understanding of the molecul...
IntroductionTo tailor local treatment in breast cancer patients there is a need for predicting ipsil...
Motivation: Patient outcome prediction using microarray technolo-gies is an important application in...
Objective Colorectal cancer (CRC) is the most common cancer worldwide. Patient outcomes following re...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Cancer is one of the deadliest diseases in the world and is responsible for around 13% of all deaths...
Cancer is one of the deadliest diseases in the world and is responsible for around 13% of all deaths...
Cancer is a major deadliest disease globally that involve uncontrolled cell growth and invasion-meta...
After numerous breakthroughs in medicine, microbiology, and pathology in the past century, lung canc...
Background: The prognosis of cancer recurrence is an important research area in bioinformatics and i...
In the last decades, several gene expression-based predictors of clinical behavior were developed fo...
Background. After curative surgical resection, about 30-75% lung adenocarcinoma (LUAD) patients suff...
[[abstract]]Background: Microarray technology can acquire information about thousands of genes simul...
AbstractAn accurate prognostic model of a cancer patient after treatment can be useful in deciding t...
MOTIVATION: In recent years, microarray technology has revealed many tumor-expressed genes prognosti...
Microarrays are being increasingly used in cancer research for a better understanding of the molecul...
IntroductionTo tailor local treatment in breast cancer patients there is a need for predicting ipsil...
Motivation: Patient outcome prediction using microarray technolo-gies is an important application in...
Objective Colorectal cancer (CRC) is the most common cancer worldwide. Patient outcomes following re...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...